ea0098c5 | Clinical – Chemo/SSA/Biologics | NANETS2023
Jimenez Camilo
, Habra Mouhammed A.
, Campbell Matthew T.
, Tamsen Gina
, Cruz-Goldberg Damaris
, Long James
, Bassett Roland
, Dantzer Robert
, Balderrama Vania
, Varghese Jeena
, Waguespack Steven
, Lu Yang
Background: Metastatic pheochromocytomas and paragangliomas are orphan neuroendocrine tumors. 50% of these tumors are associated with germline mutations of the SDHB gene. SDHB related pheochromocytomas and paragangliomas and many apparently sporadic tumors exhibit abnormal angiogenesis. This trial assessed the efficacy and safety of Cabozantinib, a potent, antiangiogenic, tyrosine kinase inhibitor. Methods: The Natalie trial is a single arm phase 2 clini...